Literature DB >> 23625821

The benefits of photodynamic therapy on vertebral bone are maintained and enhanced by combination treatment with bisphosphonates and radiation therapy.

Victor C K Lo1, Margarete K Akens, Lisa Wise-Milestone, Albert J M Yee, Brian C Wilson, Cari M Whyne.   

Abstract

Photodynamic therapy (PDT) has been shown to ablate tumors within vertebral bone and yield short-term improvements in vertebral architecture and biomechanical strength, in particular when combined with bisphosphonate (BP) treatment. Longer-term outcomes of PDT combined with current treatments for skeletal metastases are essential to understand its therapeutic potential. The objective of this study is to evaluate the response of vertebrae to PDT after a longer (6-week) time period, alone and combined with previous BP or radiation treatment (RT). Sixty-three female rnu/rnu rats were randomized to six treatment groups: untreated control, BP-only, RT-only, PDT-only, combined BP + PDT and combined RT + PDT. L2 vertebrae were structurally analyzed through µCT-based analysis, axial compressive load-to-failure testing and histological analysis of morphology, osteoid formation and osteoclast activity. Combined BP + PDT treatment yielded the largest improvements in bone architecture with combined RT + PDT treatment yielding similar findings, but of a lesser magnitude. Mechanically, ultimate force and stress were correlated to stereological parameters that demonstrated a positive structural effect from combinatory treatment. Increased osteoid formation was observed in both combination therapies without any significant differences in osteoclast activity. Overall, multimodality treatment demonstrated a sustained positive effect on vertebral structural integrity, motivating PDT as a minimally-invasive adjuvant treatment for spinal metastases.
Copyright © 2013 Orthopaedic Research Society.

Entities:  

Keywords:  bisphosphonate; photodynamic therapy; radiation therapy; spine; vertebral metastasis

Mesh:

Substances:

Year:  2013        PMID: 23625821     DOI: 10.1002/jor.22373

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  6 in total

Review 1.  The role of photodynamic therapy in overcoming cancer drug resistance.

Authors:  Bryan Q Spring; Imran Rizvi; Nan Xu; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2015-04-09       Impact factor: 3.982

2.  Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma.

Authors:  Corinne Bouvier; Nicolas Macagno; Quy Nguyen; Anderson Loundou; Carine Jiguet-Jiglaire; Jean-Claude Gentet; Jean-Luc Jouve; Alexandre Rochwerger; Jean-Camille Mattei; Daniel Bouvard; Sébastien Salas
Journal:  Oncotarget       Date:  2016-10-04

Review 3.  Progress of Phototherapy Applications in the Treatment of Bone Cancer.

Authors:  Jiachen Sun; Fei Xing; Joy Braun; Frank Traub; Pol Maria Rommens; Zhou Xiang; Ulrike Ritz
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

Review 4.  Biomechanical Properties of Metastatically Involved Osteolytic Bone.

Authors:  Cari M Whyne; Dallis Ferguson; Allison Clement; Mohammedayaz Rangrez; Michael Hardisty
Journal:  Curr Osteoporos Rep       Date:  2020-10-19       Impact factor: 5.096

5.  Hypericin-mediated photodynamic therapy induces apoptosis in K562 human leukemia cells through JNK pathway modulation.

Authors:  Yixiao Xu; Dexuan Wang; Zhizhi Zhuang; Keke Jin; Lvzhen Zheng; Qing Yang; Kunyuan Guo
Journal:  Mol Med Rep       Date:  2015-08-27       Impact factor: 2.952

6.  Photodynamic therapy outcome modelling for patients with spinal metastases: a simulation-based study.

Authors:  Abdul-Amir Yassine; William C Y Lo; Tina Saeidi; Dallis Ferguson; Cari M Whyne; Margarete K Akens; Vaughn Betz; Lothar Lilge
Journal:  Sci Rep       Date:  2021-09-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.